Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02420847
Brief Title: A Two-Dimensional Dose-Finding Study of Ixazomib in Combination With Gemcitabine and Doxorubicin, Followed by a Phase II Extension to Assess the Efficacy of This Combination in Metastatic, Surgically Unresectable Urothelial Cancer

First Submitted : April 15, 2015
First Submitted that Met QC Criteria : April 17, 2015
First Posted : April 20, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : July 18, 2018
Last Update Posted : July 20, 2018